Genetics of primary lateral sclerosis

References

• Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC. Primary lateral sclerosis: clinical features, neuropathology and diagnostic criteria. Brain. 1992;115:495–520.
   PubMed Web of Science ®Google Scholar
• Brugman F, Wokke JHJ, Vianney de Jong JMB, Franssen H, Faber CG, Van den Berg LH. Van Den Berg LH. Primary lateral sclerosis as a phenotypic manifestation of familial ALS. Neurology. 2005;64:1778–9.
   PubMed Web of Science ®Google Scholar
• Dupré N, Valdmanis PN, Bouchard JP, Rouleau GA. Autosomal dominant primary lateral sclerosis. Neurology. 2007;68:1156–7.
   PubMed Web of Science ®Google Scholar
• Valdmanis PN, Dupré N, Rouleau GA. A locus for primary lateral sclerosis on chromosome 4ptel-4p16.1. Arch Neurol. 2008;65:383–6.
   PubMedGoogle Scholar
• Praline J, Guennoc A-M, Vourc’h P, De Toffol B, Corcia P. Primary lateral sclerosis may occur within familial. Amyotrophic Lateral Sclerosis Pedigrees. Amyotroph Lateral Scler. 2010;11:154–6.
   PubMed Web of Science ®Google Scholar
• Appelbaum JS, Roos RP, Salazar-Grueso EF, Buchman A, Iannaccone S, Glantz R, et al. Intrafamilial heterogeneity in hereditary motor neuron disease. Neurology. 1992;42:1488–92.
   PubMed Web of Science ®Google Scholar
• Turner MR, Barohn RJ, Corcia P, Fink JK, Harms MB, Kiernan MC, et al. Primary lateral sclerosis: consensus diagnostic criteria. J Neurol Neurosurg Psychiatry. 2020;91:373–7.
   PubMed Web of Science ®Google Scholar
• Van Rheenen W, Van Blitterswijk M, Huisman MHB, Vlam L, Van Doormaal PTC, Seelen M, et al. Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases. Neurology. 2012;79:878–82.
   PubMed Web of Science ®Google Scholar
• Mitsumoto H, Nagy PL, Gennings C, Murphy J, Andrews H, Goetz R, et al. Phenotypic and molecular analyses of primary lateral sclerosis. Neurol Genet. 2015;1:e3.
   PubMed Web of Science ®Google Scholar
• Chen YZ, Bennett CL, Huynh HM, Blair IP, Puls I, Irobi J, et al. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet. 2004;74:1128–35.
   PubMed Web of Science ®Google Scholar
• Del Bo R, Tiloca C, Pensato V, Corrado L, Ratti A, Ticozzi N, et al. Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2011;82:1239–43.
   PubMed Web of Science ®Google Scholar
• Gellera C, Tiloca C, Del Bo R, Corrado L, Pensato V, Agostini J, et al. Ubiquilin 2 mutations in Italian patients with amyotrophic lateral sclerosis and frontotemporal dementia. J Neurol Neurosurg Psychiatry. 2013;84:183–7.
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhang L, Lynch DR, Lukas T, Ahmeti K, Sleiman PMA, et al. Compound heterozygote mutations in SPG7 in a family with adult-onset primary lateral sclerosis. Neurol Genet. 2016;2:e60.
   PubMed Web of Science ®Google Scholar
• Münch C, Sedlmeier R, Meyer T, Homberg V, Sperfeld AD, Kurt A, et al. Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology. 2004;63:724–6.
   PubMed Web of Science ®Google Scholar
• Ticozzi N, Tiloca C, Calini D, Gagliardi S, Altieri A, Colombrita C, et al. C9orf72 repeat expansions are restricted to the ALS-FTD spectrum. Neurobiol Aging. 2014;35:936.e13–7.
   Web of Science ®Google Scholar
• Yang Y, Hentati A, Deng HX, Dabbagh O, Sasaki T, Hirano M, et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet. 2001;29:160–5.
   PubMed Web of Science ®Google Scholar
• Hentati A, Bejaoui K, Pericak-Vance MA, Hentati F, Speer MC, Hung WY, et al. Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33–q35. Nat Genet. 1994;7:425–8.
   PubMed Web of Science ®Google Scholar
• Kress JA, Kühnlein P, Winter P, Ludolph AC, Kassubek J, Müller U, et al. Novel mutation in the ALS2 gene in juvenile amyotrophic lateral sclerosis. Ann Neurol. 2005;58:800–3.
   PubMed Web of Science ®Google Scholar
• Tunca C, Akçimen F, Coşkun C, Gündoğdu-Eken A, Kocoglu C, Çevik B, et al. ERLIN1 mutations cause teenage-onset slowly progressive ALS in a large Turkish pedigree. Eur J Hum Genet. 2018;26:745–8.
   PubMed Web of Science ®Google Scholar
• Hadano S, Hand CK, Osuga H, Yanagisawa Y, Otomo A, Devon RS, et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet. 2001;29:166–73.
   PubMed Web of Science ®Google Scholar
• Chow CY, Landers JE, Bergren SK, Sapp PC, Grant AE, Jones JM, et al. Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS. Am J Hum Genet. 2009;84:85–8.
   PubMed Web of Science ®Google Scholar
• Deng HX, Chen W, Hong ST, Boycott KM, Gorrie GH, Siddique N, et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011;477:211–5.
   PubMed Web of Science ®Google Scholar
• Orlacchio A, Babalini C, Borreca A, Patrono C, Massa R, Basaran S, et al. SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain. 2010;133:591–8.
   PubMed Web of Science ®Google Scholar
• Maruyama H, Morino H, Ito H, Izumi Y, Kato H, Watanabe Y, et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465:223–6.
   PubMed Web of Science ®Google Scholar
• Chow CY, Zhang Y, Dowling JJ, Jin N, Adamska M, Shiga K, et al. Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J. Nature. 2007;448:68–72.
   PubMed Web of Science ®Google Scholar
• Parodi L, Coarelli G, Stevanin G, Brice A, Durr A. Hereditary ataxias and paraparesias: clinical and genetic update. Curr Opin Neurol. 2018;31:462–71.
   PubMed Web of Science ®Google Scholar
• Novarino G, Fenstermaker AG, Zaki MS, Hofree M, Silhavy JL, Heiberg AD, et al. Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders. Science. 2014;343:506–11.
   PubMed Web of Science ®Google Scholar
• Stevanin G, Santorelli FM, Azzedine H, Coutinho P, Chomilier J, Denora PS, et al. Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. Nat Genet. 2007;39:366–72.
   PubMed Web of Science ®Google Scholar
• Reid E, Kloos M, Ashley-Koch A, Hughes L, Bevan S, Svenson IK, et al. A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am J Hum Genet. 2002;71:1189–94.
   PubMed Web of Science ®Google Scholar
• Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, et al. Genome-wide analyses identify KIF5A as a Novel ALS Gene. Neuron. 2018;97:1268–83.e6.
   PubMed Web of Science ®Google Scholar
• Musacchio T, Zaum A-K, Üçeyler N, Sommer C, Pfeifroth N, Reiners K, et al. ALS and MMN mimics in patients with BSCL2 mutations: the expanding clinical spectrum of SPG17 hereditary spastic paraplegia. J Neurol. 2017;264:11–20.
   PubMed Web of Science ®Google Scholar
• James PA, Talbot K. The molecular genetics of non-ALS motor neuron diseases. Biochim Biophys Acta. 2006;1762:986–1000.
   PubMed Web of Science ®Google Scholar
• Meyer T, Schwan A, Dullinger JS, Brocke J, Hoffmann K-T, Nolte CH, et al. Early-onset ALS with long-term survival associated with spastin gene mutation. Neurology. 2005;65:141–3.
   PubMed Web of Science ®Google Scholar
• Münch C, Rolfs A, Meyer T. Heterozygous S44L missense change of the spastin gene in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2008;9:251–3.
   PubMed Web of Science ®Google Scholar
• Krüger S, Battke F, Sprecher A, Munz M, Synofzik M, Schöls L, et al. Rare variants in neurodegeneration associated genes revealed by targeted panel sequencing in a German ALS cohort. Front Mol Neurosci. 2016;9:92.
   PubMed Web of Science ®Google Scholar
• Brugman F, Scheffer H, Wokke JHJ, Nillesen WM, De Visser M, Aronica E, et al. Paraplegin mutations in sporadic adult-onset upper motor neuron syndromes. Neurology. 2008;71:1500–5.
   PubMed Web of Science ®Google Scholar
• McDermott CJ, Roberts D, Tomkins J, Bushby KM, Shaw PJ. Spastin and paraplegin gene analysis in selected cases of motor neurone disease (MND). Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4:96–9.
   PubMedGoogle Scholar
• Sánchez-Ferrero E, Coto E, Beetz C, Gámez J, Corao A, Díaz M, et al. SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510V. Clin Genet. 2013;83:257–62.
   PubMed Web of Science ®Google Scholar
• Gascon GG, Chavis P, Yaghmour A, Stigsby B, Shums A, Ozand P, et al. Familial childhood primary lateral sclerosis with associated gaze paresis. Neuropediatrics. 1995;26:313–9.
   PubMed Web of Science ®Google Scholar
• Lerman-Sagie T, Filiano J, Smith DW, Korson M. Infantile onset of hereditary ascending spastic paralysis with bulbar involvement. J Child Neurol. 1996;11:54–7.
   PubMed Web of Science ®Google Scholar
• Grunnet ML, Leicher C, Zimmerman A, Zalneraitis E, Barwick M. Primary lateral sclerosis in a child. Neurology. 1989;39:1530.
   PubMed Web of Science ®Google Scholar
• Mintchev N, Zamba-Papanicolaou E, Kleopa KA, Christodoulou KA. A novel ALS2 splice-site mutation in a Cypriot juvenile-onset primary lateral sclerosis family. Neurology. 2009;72:28–32.
   PubMed Web of Science ®Google Scholar
• Panzeri C, De Palma C, Martinuzzi A, Daga A, De Polo G, Bresolin N, et al. The first ALS2 missense mutation associated with JPLS reveals new aspects of alsin biological function. Brain. 2006;129:1710–9.
   PubMed Web of Science ®Google Scholar
• Shirakawa K, Suzuki H, Ito M, Kono S, Uchiyama T, Ohashi T, et al. Novel compound heterozygous als2 mutations cause juvenile amyotrophic lateral sclerosis in Japan. Neurology. 2009;73:2124–6.
   PubMed Web of Science ®Google Scholar
• Siddiqi S, Foo JN, Vu A, Azim S, Silver DL, Mansoor A, et al. A novel splice-site mutation in ALS establishes the diagnosis of juvenile amyotrophic lateral sclerosis in a family with early onset anarthria and generalized dystonias. PLoS One. 2014;9:e113258.
   PubMed Web of Science ®Google Scholar
• Luigetti M, Lattante S, Conte A, Romano A, Zollino M, Marangi G, et al. A novel compound heterozygous ALS2 mutation in two Italian siblings with juvenile amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:470–2.
   PubMed Web of Science ®Google Scholar
• Devon RS, Helm JR, Rouleau GA, Leitner Y, Lerman-Sagie T, Lev D, et al. The first nonsense mutation in alsin results in a homogeneous phenotype of infantile-onset ascending spastic paralysis with bulbar involvement in two siblings. Clin Genet. 2003;64:210–5.
   PubMed Web of Science ®Google Scholar
• Gros-Louis F, Meijer IA, Hand CK, Dubé MP, MacGregor DL, Seni MH, et al. An ALS2 gene mutation causes hereditary spastic paraplegia in a Pakistani kindred [2]. Ann Neurol. 2003;53:144–5.
   PubMed Web of Science ®Google Scholar
• Eymard-Pierre E, Lesca G, Dollet S, Santorelli FM, di Capua M, Bertini E, et al. Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene. Am J Hum Genet. 2002;71:518–27.
   PubMed Web of Science ®Google Scholar
• Eymard-Pierre E, Yamanaka K, Haeussler M, Kress W, Gauthier-Barichard F, Combes P, et al. Novel missense mutation in ALS2 gene results in infantile ascending hereditary spastic paralysis. Ann Neurol. 2006;59:976–80.
   PubMed Web of Science ®Google Scholar
• Tariq H, Mukhtar S, Naz S. A novel mutation in ALS2 associated with severe and progressive infantile onset of spastic paralysis. J Neurogenet. 2017;31:26–9.
   PubMed Web of Science ®Google Scholar
• Helal M, Mazaheri N, Shalbafan B, Malamiri RA, Dilaver N, Buchert R, et al. Clinical presentation and natural history of infantile-onset ascending spastic paralysis from three families with an ALS2 founder variant. Neurol Sci. 2018;39:1917–25.
   PubMed Web of Science ®Google Scholar
• Daud S, Kakar N, Goebel I, Hashmi AS, Yaqub T, Nürnberg G, et al. Identification of two novel ALS2 mutations in infantile-onset ascending hereditary spastic paraplegia. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:260–5.
   PubMed Web of Science ®Google Scholar
• Xie F, Cen Z-D, Xiao J-F, Luo W. Novel compound heterozygous ALS2 mutations in two Chinese siblings with infantile ascending hereditary spastic paralysis. Neurol Sci. 2015;36:1279–80.
   PubMed Web of Science ®Google Scholar
• Koçak Eker H, Ünlü SE, Al-Salmi F, Crosby AH. A novel homozygous mutation in ALS2 gene in four siblings with infantile-onset ascending hereditary spastic paralysis. Eur J Med Genet. 2014;57:275–8.
   PubMed Web of Science ®Google Scholar
• Brugman F, Eymard-Pierre E, Van Den Berg LH, Wokke JHJ, Gauthier-Barichard F, Boespflug-Tanguy O. Adult-onset primary lateral sclerosis is not associated with mutations in the ALS2 gene. Neurology. 2007;69:702–4.
   PubMed Web of Science ®Google Scholar
• Otomo A, Hadano S, Okada T, Mizumura H, Kunita R, Nishijima H, et al. ALS2, a novel guanine nucleotide exchange factor for the small GTPase Rab5, is implicated in endosomal dynamics. Hum Mol Genet. 2003;12:1671–87.
   PubMed Web of Science ®Google Scholar
• Gautam M, Jara JH, Sekerkova G, Yasvoina MV, Martina M, Özdinler PH. Absence of alsin function leads to corticospinal motor neuron vulnerability via novel disease mechanisms. Hum Mol Genet. 2016;25:1074–87.
   PubMed Web of Science ®Google Scholar
• Al-Saif A, Bohlega S, Al-Mohanna F. Loss of ERLIN2 function leads to juvenile primary lateral sclerosis. Ann Neurol. 2012;72:510–6.
   PubMed Web of Science ®Google Scholar
• Alazami AM, Adly N, Al Dhalaan H, Alkuraya FS. A nullimorphic ERLIN2 mutation defines a complicated hereditary spastic paraplegia locus (SPG18). Neurogenetics. 2011;12:333–6.
   PubMed Web of Science ®Google Scholar